Register Cart 0

Generic placeholder image

Clinical Cancer Drugs

Editor-in-Chief

ISSN (Print): 2212-697X
ISSN (Online): 2212-6988

Back Subscribe

Biography

Meet Our Editor-in-Chief

Author(s): Giulio Francia

Volume 5, Issue 2, 2018

Page: [65 - 67] Pages: 3

DOI: 10.2174/2212697X0502190131161027

Rights & Permissions Print Cite

Article Metrics

31

1

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

The Role of Organic Transporters in Pharmacokinetics and Nephrotoxicity of Newer Antiviral Therapies for HIV and Hepatitis C
Current Drug Metabolism

Mediterranean Diet and Dementia of the Alzheimer Type
Current Aging Science

Regulation of Cellular Signal Transduction Pathways by the Extracellular Calcium-Sensing Receptor
Current Pharmaceutical Biotechnology

Olive Oil and Cancer Risk: an Update of Epidemiological Findings through 2010
Current Pharmaceutical Design

Cytotoxic Properties of Clofibrate and other Peroxisome Proliferators: Relevance to Cancer Progression
Current Medicinal Chemistry

New Insight into P-Glycoprotein as a Drug Target
Anti-Cancer Agents in Medicinal Chemistry

Advances in Bioconjugation
Current Organic Chemistry

Targeting Steroid Hormone Receptor Pathways in the Treatment of Hormone Dependent Cancers
Current Pharmaceutical Biotechnology

Genes of Human Longevity: An Endless Quest?
Current Vascular Pharmacology

Incretin-Based Therapies, Glucometabolic Health and Endovascular Inflammation
Current Pharmaceutical Design

Vitamin D Receptor Modulators for Inflammation and Cancer
Mini-Reviews in Medicinal Chemistry

Editorial [Hot Topic: Thyroid: From Genes to the Disease (Guest Editor: Katja Zaletel)]
Current Genomics

Critical Aspects to be Considered Prior to Large-Scale Production of Peptides
Current Protein & Peptide Science

PEGylation of Proteins and Liposomes: a Powerful and Flexible Strategy to Improve the Drug Delivery
Current Drug Metabolism

Therapeutic Potential of Autotaxin/Lysophospholipase D Inhibitors
Current Drug Targets

GLP-1 Agonists Exenatide and Liraglutide: A Review About Their Safety and Efficacy
Current Clinical Pharmacology

C-terminus of Hsp70 Interacting Protein (CHIP) and Neurodegeneration: Lessons from the Bench and Bedside
Current Neuropharmacology

RNAi in Plasmodium
Current Pharmaceutical Design

Emerging Risk Factors for Cerebrovascular Disease
Current Drug Targets

The Impact of Molecularly Targeted Therapies Upon the Understanding of Leukemogenesis and the Role of Hematopoietic Stem Cell Transplantation in Acute Promyelocytic Leukemia
Current Stem Cell Research & Therapy

© 2024 Bentham Science Publishers | Privacy Policy